Law & Society

In light of the widespread Zika Virus going on in different parts of the world, the U.S. Congress have responded in aiding a Zika drug development through the approval of a bill. The bill will be providing financial incentives for companies that will be pursuing a Zika drug development.

The Government Accountability Office claimed that big banks do not have enough information oh how U.S. regulators evaluate living wills. They are also scrambling to meet the yearly deadlines for filing a "living will."

The heads of the U.S. agencies that regulate securities and commodities pressed a Senate committee. They are asking the U.S. Congress to boost their budgets as the financial markets and technology continue to grow.